InsiderTrades

Form 4 for EW Edwards Lifesciences

Accepted 2022-06-13 00:00:00 ET · period of report 2022-06-13 · accession 0001225208-22-008029 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-06-13 2022-06-13 EW BOBO DONALD E JR CVP, Strategy, Corp Development M - OptEx $35.20 +6,725 69.3K +11% +$236.7K
DM 2022-06-13 2022-06-13 EW BOBO DONALD E JR CVP, Strategy, Corp Development S - Sale+OE $90.02 -6,725 62.6K -10% -$605.4K
D 2022-06-13 2022-06-13 EW BOBO DONALD E JR CVP, Strategy, Corp Development M - OptEx $0.00 -6,725 67.2K -9% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-06-13 M A 6,725 $35.20 69,285.78 D — —
2 Common Common Stock 2022-06-13 S D 1,100 $90.50 68,185.78 D — — (F2) This transaction was executed in multiple trades at prices ranging from $90.32 to $90.69. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
3 Common Common Stock 2022-06-13 S D 5,625 $89.93 62,560.78 D — — (F3) This transaction was executed in multiple trades at prices ranging from $89.31 to $90.30. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
4 Derivative Employee Stock Option (Right to Acquire) 2022-06-13 M D 6,725 $0.00 67,250 D $35.20 · 2017-05-12 to 2023-05-11 6,725 Common Stock